Epidemiologic data consistently indicate that colorectal cancer survivors can improve their quality-of-life and prognosis by engaging in physical activity. This study aims to build on this epidemiologic work and translate the findings to inform and change patient behavior. The specific aims are to: (1) Develop a mobile technology physical activity intervention among colorectal cancer patients who have completed therapy. (2) Conduct a 3-month pilot randomized controlled trial utilizing mobile technology to increase physical activity among 40 men and women who have completed standard cytotoxic chemotherapy for primary stage I-III colorectal cancer at the UCSF Helen Diller Family Comprehensive Cancer Center. Participants in the intervention arm will receive a Fitbit® for self-monitoring, interactive text messages, and educational print materials; participants in the control arm will receive educational print materials at baseline and will be given a Fitbit® after completion of the 3-mo. follow-up assessment.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Enrollment
42
Print materials on exercise after cancer, Fitbit Flex for 12 weeks, and daily Text Messages for 12 weeks
University of California, San Francisco
San Francisco, California, United States
Physical activity
Change in total physical activity assessed via ActiGraph GT3X+ accelerometers
Time frame: 12-weeks
Fitbit wear time (# days with data / # days of observation)
Time frame: 12-weeks
Response to text messages (# of messages responded to / # of messages that asked for a response)
Time frame: 12-weeks
Quality-of-life (SF--36)
Time frame: 12-weeks
Colorectal cancer-specific quality-of-life (FACT-C)
Time frame: 12-weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.